TRDA
Entrada Therapeutics·NASDAQ
--
--(--)
--
--(--)
TRDA fundamentals
Entrada Therapeutics (TRDA) released its earnings on Aug 6, 2025: revenue was 1.95M (YoY -97.94%), missed estimates; EPS was -1.04 (YoY -167.10%), missed estimates.
Revenue / YoY
1.95M
-97.94%
EPS / YoY
-1.04
-167.10%
Report date
Aug 6, 2025
EPS
Actual | -9.78 | -0.89 | -0.69 | -0.74 | -0.8 | -0.79 | -0.21 | -0.78 | 1.02 | -0.29 | 0.68 | 1.55 | -0.35 | 0.03 | -0.42 | -1.04 |
Forecast | -0.87 | -1.285 | -0.655 | -0.725 | -0.76 | -0.8273 | -0.6512 | -0.6898 | -0.735 | -0.1684 | -0.594 | 0.3614 | -0.728 | -0.6698 | -0.7886 | -0.8472 |
Surprise | -1024.14% | +30.74% | -5.34% | -2.07% | -5.26% | +4.51% | +67.75% | -13.08% | +238.78% | -72.21% | +214.48% | +328.89% | +51.92% | +104.48% | +46.74% | -22.76% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 | 25.26M | 18.17M | 43.73M | 41.85M | 59.12M | 94.69M | 19.57M | 37.40M | 20.56M | 1.95M |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 7.00M | 9.78M | 9.60M | 23.69M | 14.98M | 51.86M | 12.32M | 13.12M | 10.17M | 9.65M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +260.86% | +85.86% | +355.69% | +76.66% | +294.75% | +82.60% | +58.83% | +185.04% | +102.12% | -79.80% |
Earnings Call
You can ask Aime
What is Entrada Therapeutics's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Entrada Therapeutics year over year?What is Entrada Therapeutics's gross profit margin?What were the key takeaways from Entrada Therapeutics's earnings call?What is the market's earnings forecast for Entrada Therapeutics next quarter?What guidance did Entrada Therapeutics's management provide for the next earnings period?What does Entrada Therapeutics do and what are its main business segments?What were the key takeaways from Entrada Therapeutics’s earnings call?
